These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 9803678
1. Granulocyte colony-stimulating factor (G-CSF) dependent hematopoiesis with monosomy 7 in a patient with severe aplastic anemia after ATG/CsA/G-CSF combined therapy. Nishimura M, Yamada T, Andoh T, Tao T, Emoto M, Ohji T, Matsuda K, Kameda N, Satoh Y, Matsutani A, Azuno Y, Oka Y. Int J Hematol; 1998 Aug; 68(2):203-11. PubMed ID: 9803678 [Abstract] [Full Text] [Related]
2. [Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia]. Tsuzuki M, Okamoto M, Yamaguchi T, Ino T, Ezaki K, Hirano M. Rinsho Ketsueki; 1997 Sep; 38(9):745-51. PubMed ID: 9364865 [Abstract] [Full Text] [Related]
3. Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Kaito K, Kobayashi M, Katayama T, Masuoka H, Shimada T, Nishiwaki K, Sekita T, Otsubo H, Ogasawara Y, Hosoya T. Br J Haematol; 1998 Nov; 103(2):297-303. PubMed ID: 9827895 [Abstract] [Full Text] [Related]
9. Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor. Otsubo H, Kaito K, Sekita T, Shimada T, Kobayashi M, Hosoya T. Int J Hematol; 1998 Dec; 68(4):445-8. PubMed ID: 9885444 [Abstract] [Full Text] [Related]
10. Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation. Tichelli A, de Latour RP, Passweg J, Knol-Bout C, Socié G, Marsh J, Schrezenmeier H, Höchsmann B, Bacigalupo A, Samarasinghe S, Rovó A, Kulasekararaj A, Röth A, Eikema DJ, Bosman P, Bader P, Risitano A, Dufour C, SAA Working Party of the EBMT. Haematologica; 2020 May; 105(5):1223-1231. PubMed ID: 31582549 [Abstract] [Full Text] [Related]
11. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults. Zhu X, Guan J, Xu J, Wei J, Jiang L, Yin J, Zhao L, Zhang Y. Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461 [Abstract] [Full Text] [Related]
16. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF. Imashuku S, Hibi S, Bessho F, Tsuchida M, Nakahata T, Miyazaki S, Tsukimoto I, Hamajima N, Pediatric AA Follow-up Study Group in Japan. Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763 [Abstract] [Full Text] [Related]
20. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Locasciulli A, Arcese W, Locatelli F, Di Bona E, Bacigalupo A, Italian Aplastic Anaemia Study Group. Lancet; 2001 Jan 06; 357(9249):43-4. PubMed ID: 11197365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]